Our Impact

Thirteen Damon Runyon scientists have received the Nobel Prize.

Since our founding in 1946, promising scientists identified and supported by Damon Runyon have gone on to make breakthrough discoveries that have transformed our understanding of cancer and develop new approaches to prevention, diagnosis and treatment of all forms of this disease.

We fund revolutionaries. They just happen to work in labs.
In partnership with donors across the nation, we have invested nearly $420 million and funded more than 3,900 scientists. Damon Runyon cancer researchers have made extraordinary breakthroughs in every area of cancer prevention, diagnosis, and treatment.

To this day, we support the next generation of leaders: emerging talent with unique insights, drive, and boundless vision. We will not stop until we have the tools to prevent or cure all cancers.
We fund revolutionaries. They just happen to work in labs.
In partnership with donors across the nation, we have invested nearly $420 million and funded more than 3,900 scientists. Damon Runyon cancer researchers have made extraordinary breakthroughs in every area of cancer prevention, diagnosis, and treatment.

To this day, we support the next generation of leaders: emerging talent with unique insights, drive, and boundless vision. We will not stop until we have the tools to prevent or cure all cancers.
We fund revolutionaries. They just happen to work in labs.
In partnership with donors across the nation, we have invested nearly $420 million and funded more than 3,900 scientists. Damon Runyon cancer researchers have made extraordinary breakthroughs in every area of cancer prevention, diagnosis, and treatment.

To this day, we support the next generation of leaders: emerging talent with unique insights, drive, and boundless vision. We will not stop until we have the tools to prevent or cure all cancers.

We measure our impact in three ways:

Scientific discoveries that advance our understanding of cancer

Our scientists have:

Been front and center in deciphering the genetic drivers of cancer, including identifying the first cancer-causing gene and leadership in the national Human Genome Atlas project to identify the key genetic drivers of a broad range of cancers.

Pioneered the study of the immune system, which has led to the current success of cancer immunotherapies.

Developed many of the technologies used today to study cancer, such as tools to edit the genome (CRISPR Cas9) and study cancer at the single cell level.

And the list goes on...

Development of new approaches to prevention, diagnosis and treatment

Our scientists:

Proved the link between cigarette smoking and cancer

First cured a solid tumor with chemotherapy

First cured a patient with Stage IV melanoma using only immunotherapy Were directly involved in the development and approval of new targeted therapies such as Herceptin, Erbitux, Yervoy, and Zelboraf. In fact, in an analysis of 12 recently approved cancer drugs, discoveries by Damon Runyon scientists were cited as important in each one

Have founded innovative biotech companies, such as Juno Therapeutics, Syros Pharmaceuticals, Sunesis Pharmaceuticals, and others

And the list goes on...

The career success of the scientists we were the first to identify and support

Our scientists have gone on to recieve:

13 Noble Prize Winners

15 Lasker Award Winner

7 National Medal of Science Winners

97 National Academy of Science Members 41 National Academy of Medicine Members

13

Nobel Prize Winners

15

Lasker Award Winners

7

National Medal of Science Winners

97

National Academy of Sciences Members

15

National Academy of Medicine Members

Our Impact

Thirteen Damon Runyon scientists have received the Nobel Prize.

We fund revolutionaries. They just happen to work in labs.

We fund revolutionaries. They just happen to work in labs.

We fund revolutionaries. They just happen to work in labs.

We measure our impact in three ways:

Scientific discoveries that advance our understanding of cancer

Development of new approaches to prevention, diagnosis and treatment

The career success of the scientists we were the first to identify and support

13

15

7

97

15

NEWSLETTER